Janet Freeman-DailyOvjeren akaunt

@JFreemanDaily

Writer, speaker, science geek, lung cancer patient/activist. Chat mod, co-founder, & alum, aerospace systems engineer (retd)

Seattle area
grayconnections.net
Vrijeme pridruživanja: lipanj 2009.
723 fotografije ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @JFreemanDaily

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @JFreemanDaily

  1. proslijedio/la je Tweet
    prije 16 sati
    Odgovor korisnicima i sljedećem broju korisnika:

    Great to have the opportunity to share our work on using hashtags in cancer care through

    3 proslijeđena tweeta 12 korisnika označava da im se sviđa
    Poništi
  2. proslijedio/la je Tweet
    prije 16 sati

    Check out ASCO's most read articles of 2019! (Hint, I'm a co-author of 1, w/the greats!)

    12 proslijeđenih tweetova 14 korisnika označava da im se sviđa
    Poništi
  3. proslijedio/la je Tweet
    3. velj

    Nobody deserves lung cancer.

    What do Ruth Bader Ginsburg and Rush Limbaugh have in common? LUNG CANCER. Anyone with lungs can get it. No risk factors required. This disease afflicts anyone regardless of political beliefs. NO ONE deserves Lung Cancer or any disease.
    Prikaži ovu nit
    9 proslijeđenih tweetova 23 korisnika označavaju da im se sviđa
    Poništi
  4. proslijedio/la je Tweet
    31. sij

    Healthy cells in smokers’ lungs have a high burden of mutations, similar to the mutational profile of lung cancer. ⁦⁩

    34 proslijeđena tweeta 67 korisnika označava da im se sviđa
    Poništi
  5. proslijedio/la je Tweet
    prije 23 sata

    Are doctors & patients still nihilistic about a new dx of lung cancer? How can we better study the effects of stigma & nihilism on cancer patients? Join us this Thursday at 8pm ET/5pm PT as we discuss this & more during Chat. Read more here:

    , , i još njih 7
    12 proslijeđenih tweetova 14 korisnika označava da im se sviđa
    Poništi
  6. proslijedio/la je Tweet
    prije 24 sata

    How does stigma affect lung cancer patients & research? What can we as a group do to best address stigma & nihilism? Join us this Thursday at 8pm ET/5pm PT for Chat as we brainstorm. Read more here:

    , , i još njih 7
    1 reply 10 proslijeđenih tweetova 29 korisnika označava da im se sviđa
    Poništi
  7. proslijedio/la je Tweet
    3. velj

    Another one bites the dust. This time an anti-ganglioside antibody with immunotherapeutic properties. Sad news, indeed. United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint.

    1 reply 10 proslijeđenih tweetova 20 korisnika označava da im se sviđa
    Poništi
  8. 2. velj

    The lung cancer community lost a dedicated, compassionate advocate today, and I lost a good friend. Journey on, Don "Superman" Stranathan (). You are missed.

    14 replies 13 proslijeđenih tweetova 75 korisnika označava da im se sviđa
    Poništi
  9. proslijedio/la je Tweet
    1. velj

    Great collaborative paper DFCI MSKCC MDACC: PDL1 50% is not a magical number for selecting 1L pembro- it's a continuous variable w increasingly better outcomes the higher the PDL1.

    55 proslijeđenih tweetova 148 korisnika označava da im se sviđa
    Poništi
  10. 31. sij

    Looking for rapid autopsy program interested in collecting cancer tumor tissue shortly after death for research. Asking for patient nearing end of life who wants to make arrangements. If you know a program near Los Angeles CA, please name facility.

    6 replies 16 proslijeđenih tweetova 36 korisnika označava da im se sviđa
    Poništi
  11. proslijedio/la je Tweet
    31. sij

    We may have a vaccine in record time.

    A dozen #2019-nCoV vaccine development programs have been announced, five efforts to discover and develop therapeutic antibodies.
    25 replies 83 proslijeđena tweeta 199 korisnika označava da im se sviđa
    Poništi
  12. proslijedio/la je Tweet
    29. sij

    BREAKING: FDA Grants Priority Review to Selpercatinib in RET fusion+ non–small cell lung cancer, RET-mutant medullary thyroid cancer, and RET fusion–positive thyroid cancer, based on results from the phase I/II LIBRETTO-001 trial.

    4 proslijeđena tweeta 7 korisnika označava da im se sviđa
    Poništi
  13. proslijedio/la je Tweet
    28. sij

    An electronic records company, used by doctors, admits that it TOOK KICKBACKS to INCREASE OPIOID PRESCRIPTIONS.

    10 replies 67 proslijeđenih tweetova 69 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  14. 26. sij

    Great thread with important comments about treating Leptomeningeal Disease (LMD) in non-small cell (NSCLC), and not just for EGFR+ patients. Wish all responses included so more would read them.

    I have a young patient with EGFR mutated mNSCLC with leptomeningeal mets on osimertinib 80 mg/d. Insurance has denied coverage for 160 mg/d, despite referencing BLOOM study. Curious to know if others had similar issues?
    Prikaži ovu nit
    8 proslijeđenih tweetova 16 korisnika označava da im se sviđa
    Poništi
  15. proslijedio/la je Tweet
    24. sij

    Patients, especially those of us with disease, for whom it is a marathon, not a sprint, agree. We hope will consider this.

    OPEN LETTER to Director “Having endeavored for 3 years to promote methodologic innovation in [ ], I now conclude that progress here depends utterly on FDA leadership.” cc
    1 reply 4 proslijeđena tweeta 21 korisnik označava da mu se sviđa
    Poništi
  16. proslijedio/la je Tweet
    25. sij

    I didn't see this talk because I've been on the DAA beat for years, but this bears repeating: can be treated, almost everyone can be cured, cure reduces risk & those who already have HCC can be treated too!

    HCC-Treatment of hep C Maddur MD
    10 proslijeđenih tweetova 9 korisnika označava da im se sviđa
    Poništi
  17. proslijedio/la je Tweet
    23. sij

    Seattle people: There is a scam phone call going down that purports to be from Seattle City Light. Looks legit on your phone, the callback # sounds legit. They threaten to cut off your service in 30 minute if you don't pay $400 cash. Ignore them.

    1 reply 11 proslijeđenih tweetova 9 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  18. proslijedio/la je Tweet
    22. sij
    Odgovor korisniku/ci

    “The patient failed treatment x.” Patients 👋 never 👋 fail 👋 therapies. Our therapies fail our patients (too often). Amazed how persistent this phraseology still is!

    4 proslijeđena tweeta 15 korisnika označava da im se sviđa
    Poništi
  19. proslijedio/la je Tweet
    22. sij

    Love our University of Colorado lung clinical and research team. Thanks for a great 2019 and here's to an even better 2020!

    5 proslijeđenih tweetova 44 korisnika označavaju da im se sviđa
    Poništi
  20. 22. sij

    Healthcare workers, advocates, and media need to choose words carefully to avoid raising false hopes. One of my pet peeves: using "cancer-free" to describe a metastatic patient who had a clear scan while on a TKI. What language bugs you?

    14 replies 6 proslijeđenih tweetova 61 korisnik označava da mu se sviđa
    Poništi

@JFreemanDaily još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·